Abstract
Cytomegalovirus (CMV) reactivation is a well-recognised complication of solid organ and stem cell transplantation, causing both direct cytopathology in various organs and indirect immunomodulating effects. However, reactivation also occurs in 14-71% of previously immunocompetent critically ill adults, and although final proof of pathogenicity in such patients is lacking, many studies
... read more